Medscape

Microarray-Based Prenatal Diagnosis for the Identification of Fetal Chromosome Abnormalities

JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
News-Medical.Net

Noninvasive sequencing expands prenatal genetic screening capabilities

While non-invasive prenatal testing (NIPT) has revolutionised prenatal diagnostics by allowing the detection of a number of ...
Nature

From DNA microarrays to somatic mosaicism in population cohorts

Cells that acquire somatic mutations conferring a survival advantage can expand clonally, which in some cases leads to cancer. In the haematopoietic system — which is readily accessible through blood ...
Nasdaq

Myriad Genetics expands access to at-home early fetal sex DNA test

Myriad Genetics (MYGN) continues to empower parents with increased access to prenatal testing. SneakPeek is now available over the counter in more than 8,800 retail locations nationwide. The product ...
Nature

Genetic correlation between fetal nuchal translucency thickening and cystic hygroma and exploration of pregnancy outcome

Chromosome microarray analysis (CMA) and whole exome sequencing (WES) are increasingly utilized in prenatal diagnosis of abnormal ultrasound findings, but studies on correlation between pathogenic ...
The Economist

A routine test for fetal abnormalities could improve a mother’s health

WHEN NON-INVASIVE prenatal testing (NIPT) arrived in 2011, it transformed pregnancy. With a simple blood test, scientists could now sweep a mother’s bloodstream for scraps of placental DNA, uncovering ...
Medical Xpress

Results of non-invasive prenatal testing compare well to those from invasive methods, with better safety and cost

While noninvasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by allowing the detection of a number of genetic problems in a fetus, it is currently limited and thus misses many ...
Business Wire

Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of Natera’s expanded 21-gene Fetal Focus single gene ...
Nasdaq

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

SALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...
Nanowerk

Microarray Definition: How DNA Microarrays Work, Types, and Uses

Definition: A microarray is a small, flat substrate carrying an ordered grid of microscopic probe features, each containing a known biological molecule, that is used to measure many molecular targets ...
EurekAlert!

Maternal age over 40 increases risk of fetal DNA errors by up to 50-fold

When 58-year-old Lilian Chan, the wife of Hong Kong actor Brian Wong Chak Fung, announced that she was expecting her second child. Her story sparked public conversations about the realities and ...